HYPERION DEFI, INC.HYPDEarnings & Financial Report
Nasdaq · Health Care · Pharmaceutical Preparations
Revenue
$1.6K
Gross Profit
N/A
Operating Profit
$-7.3M
Net Profit
$-7.9M
Gross Margin
N/A
Operating Margin
-451195.5%
Net Margin
-485406.3%
YoY Growth
35.6%
EPS
$-9.07
HYPERION DEFI, INC. Q3 FY2024 Financial Summary
HYPERION DEFI, INC. reported revenue of $1.6K (up 35.6% YoY) for Q3 FY2024, with a net profit of $-7.9M (down 7.5% YoY) (-485406.3% margin).
Key Financial Metrics
| Total Revenue | $1.6K |
|---|---|
| Net Profit | $-7.9M |
| Gross Margin | N/A |
| Operating Margin | -451195.5% |
| Report Period | Q3 FY2024 |
HYPERION DEFI, INC. Annual Revenue by Year
HYPERION DEFI, INC. annual revenue history includes year-by-year totals (for example, 2025 revenue was $813.5K).
| Year | Annual Revenue |
|---|---|
| 2025 | $813.5K |
| 2024 | $57.3K |
HYPERION DEFI, INC. Quarterly Revenue & Net Profit History
HYPERION DEFI, INC. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $496.2K | +1666.4% | N/A | N/A |
| Q3 FY2025 | $302.5K | +18515.8% | $6.6M | 2190.2% |
| Q2 FY2025 | $0 | — | $-8.7M | N/A |
| Q1 FY2025 | $14.7K | +194.8% | $-3.5M | -23665.3% |
| Q4 FY2024 | $28.1K | — | N/A | N/A |
| Q3 FY2024 | $1.6K | +35.6% | $-7.9M | -485406.3% |
| Q2 FY2024 | $22.6K | — | $-11.1M | -48856.1% |
| Q1 FY2024 | $5.0K | — | $-10.9M | -218748.3% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4993 | $22625 | $1625 | $28093 | $14720 | $0 | $302506 | $496229 |
| YoY Growth | N/A | N/A | 35.6% | N/A | 194.8% | N/A | 18515.8% | 1666.4% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $26.2M | $19.0M | $22.8M | $3.7M | $6.0M | $55.7M | $82.8M | $51.8M |
| Liabilities | $24.4M | $21.4M | $19.1M | $16.8M | $15.7M | $18.3M | $12.0M | $10.7M |
| Equity | $1.8M | $-2.4M | $3.7M | $-13.1M | $-9.7M | $37.4M | $70.8M | $41.1M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-9.9M | $-8.2M | $-5.9M | $-30.1M | $-4.4M | $-3.4M | $-2.8M | $-4.1M |